Farletuzumab-MMAE | Read Reviews & Product Use Citations

Farletuzumab-MMAE is an antibody-drug conjugate (ADC) composed of humanized anti-human folate receptor-alpha (FRα) and the cytotoxic agent monomethyl auristatin (MMAE) via a MC-Vc linker. It has a potent antitumor activity.

CAS No.

Click to purchase products related to Farletuzumab-MMAE

Purity & Quality Control

Batch: D401501 Purity: 99% Protein concentration: 5.59mg/ml Endotoxin Level: ＜1EU/mg

99

Biological Activity

Description	Farletuzumab-MMAE is an antibody-drug conjugate (ADC) composed of humanized anti-human folate receptor-alpha (FRα) and the cytotoxic agent monomethyl auristatin (MMAE) via a MC-Vc linker. It has a potent antitumor activity.

References
[1] Cheng X, et al. Mol Cancer Ther (2018) 17 (12): 2665–2675.

References

[1] Cheng X, et al. Mol Cancer Ther (2018) 17 (12): 2665–2675.

Product Details

ADC antiody	Farletuzumab
ADC cytotoxin	MMAE
Formulation	1xPBS
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field